Dr. Pavani Chalasani
Claim this profileUniversity of Arizona Cancer Center
Expert in Breast Cancer
Studies Peripheral Neuropathy
15 reported clinical trials
31 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage II
HER2 negative
2Peripheral Neuropathy
Affiliated Hospitals
Clinical Trials Pavani Chalasani is currently running
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial. The phase 1b part of the trial aims to determine the RP2D of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, abemaciclib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast cancer.
Recruiting1 award Phase 1 & 2
More about Pavani Chalasani
Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Pavani Chalasani has experience with
- Palbociclib
- Paclitaxel
- PD-1 Inhibitor
- Fulvestrant
- Docetaxel
- Bortezomib
Breakdown of trials Pavani Chalasani has run
Breast Cancer
Peripheral Neuropathy
Head and Neck Cancers
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pavani Chalasani specialize in?
Pavani Chalasani focuses on Breast Cancer and Peripheral Neuropathy. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage II.
Is Pavani Chalasani currently recruiting for clinical trials?
Yes, Pavani Chalasani is currently recruiting for 8 clinical trials in Tucson Arizona. If you're interested in participating, you should apply.
Are there any treatments that Pavani Chalasani has studied deeply?
Yes, Pavani Chalasani has studied treatments such as Palbociclib, Paclitaxel, PD-1 inhibitor.
What is the best way to schedule an appointment with Pavani Chalasani?
Apply for one of the trials that Pavani Chalasani is conducting.
What is the office address of Pavani Chalasani?
The office of Pavani Chalasani is located at: University of Arizona Cancer Center, Tucson, Arizona 85724 United States. This is the address for their practice at the University of Arizona Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.